Metformin for anti-aging in COPD
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests if the diabetes drug metformin can slow down aging-related lung decline in people with COPD. You may qualify if you have moderate-to-severe COPD with emphysema and a history of smoking.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 40 and 75 years old
- Have a COPD diagnosis with moderate to severe airflow obstruction
- Have smoked at least 10 pack-years (e.g., 1 pack a day for 10 years)
- Have a confirmed decrease in lung function over the last 3 years
- Have some emphysema seen on a CT scan
- Not have advanced kidney disease, diabetes, or be on certain other medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at lung function in people with early COPD (chronic obstructive pulmonary disease) to understand what happens over time. If you meet the lung test and health requirements, you may be able to help researchers learn how to better track and manage early COPD.
This trial tests if metformin, a diabetes pill, can help older adults with COPD recover better from flare-ups when taken during pulmonary rehabilitation. It focuses on people who have had frequent or severe COPD exacerbations in the last year.
This study tests whether metformin can help slow aging in healthy men. You might be eligible if you are a man in one of two age groups and do not have major health problems.
This study tests whether metformin, a common diabetes medication, can slow the worsening of lung function in people with idiopathic pulmonary fibrosis (IPF)—a serious condition where lung tissue becomes scarred and stiff. Researchers believe metformin may help protect lungs from further damage.
This study tests whether metformin, a common diabetes drug, can help people with multiple sclerosis (MS) as they age. It may be used alone or added to your current MS treatment, and the goal is to see if it slows down aging-related changes in MS.
This trial tests whether the diabetes drug metformin can help people with asthma who are also overweight or obese. The goal is to see if it improves asthma control and reduces the need for rescue medications.
Hear when a new COPD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.